Feds' Biotech Enforcement Efforts Are Too Heavy-Handed
By Douglas Hallward-Driemeier, Laura Hoey and Alison Fethke ( May 13, 2024, 5:26 PM EDT) -- A recent federal government settlement involving California-based biotech Ultragenyx is the latest example of how the U.S. Department of Justice's heavy-handed approach to enforcement of the federal Anti-Kickback Statute can punish and deter conduct that benefits patients and poses little risk of fraud and abuse....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.